Answer
Iodixanol injection carries an increased risk of delayed reactions, including flu-like symptoms or skin reactions, in patients treated with interleukin-2 less than two weeks before the injection.
Sources for this answer
- VISIPAQUE 320 mg I/ml Solution for Injection, glass container and polypropylene containerGE Healthcare Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 6Document updated
Sources checked